---
figid: PMC3797025__jnci.j_djt263_f0007
figtitle: Schematic model of adaptive primary resistant responses by tumors to anti–IGF-1R
  monoclonal antibodies (mAbs)
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3797025
filename: jnci.j_djt263_f0007.jpg
figlink: /pmc/articles/PMC3797025/figure/F7/
number: F7
caption: Schematic model of adaptive primary resistant responses by tumors to anti–IGF-1R
  monoclonal antibodies (mAbs). IGF/IGF-1R interaction stimulates downstream pathway
  with tumor progression. Tumors respond to IGF/IGF-1R pathway inhibition with anti–IGF-1R
  mAb, but mechanisms of primary resistance to the treatment are induced via alternative
  proliferative and survival signals through IGF/integrin β3 interaction and integrin-Src
  signaling cascade. Targeting integrin β3 or Src overcomes resistance to anti–IGF-1R
  mAbs. IGF-1R = insulin-like growth factor 1 receptor.
papertitle: Combating Resistance to Anti-IGFR Antibody by Targeting the Integrin β3-Src
  Pathway.
reftext: Dong Hoon Shin, et al. J Natl Cancer Inst. 2013 Oct 16;105(20):1558-1570.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9470642
figid_alias: PMC3797025__F7
figtype: Figure
redirect_from: /figures/PMC3797025__F7
ndex: 267f4d36-de9d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3797025__jnci.j_djt263_f0007.html
  '@type': Dataset
  description: Schematic model of adaptive primary resistant responses by tumors to
    anti–IGF-1R monoclonal antibodies (mAbs). IGF/IGF-1R interaction stimulates downstream
    pathway with tumor progression. Tumors respond to IGF/IGF-1R pathway inhibition
    with anti–IGF-1R mAb, but mechanisms of primary resistance to the treatment are
    induced via alternative proliferative and survival signals through IGF/integrin
    β3 interaction and integrin-Src signaling cascade. Targeting integrin β3 or Src
    overcomes resistance to anti–IGF-1R mAbs. IGF-1R = insulin-like growth factor
    1 receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Igf1r
  - Egfr
  - Pik3r1
  - Zhx2
  - ras
  - Hras
  - Kras
  - Rem1
  - Ptk2
  - Akt1
  - Ephb2
  - Mapk1
  - Src
  - Cacnb3
  - Gabrb3
  - Bhlhe22
  - Mtor
  - Igf1
  - IGF1R
  - EGFR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - KRAS
  - HRAS
  - NRAS
  - PTK2
  - IGF1
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - SRC
  - FGR
  - FYN
  - YES1
  - EEF1B2P2
  - BHLHE22
  - MTOR
  - mab
  - scb
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Ras64B
  - Ras85D
  - Fak
  - Akt
  - Erk7
  - rl
  - Src42A
  - Csk
  - Src64B
  - rb
  - betaTub60D
  - Prosbeta3
  - Tor
  - Cancer
  - Lung cancer
---
